Stocks · Health care · Pharmaceutical Preparations

Arcturus Therapeutics Holdings Inc.

ARCT Clue Score46
United States Fiscal year ends December CIK 0001768224
$13.74 +6.76% Close, 9 Oct 2026
Price $13.74 −68.03% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Revenue15.8Operating income−21.8Net income−21.8Fiscal year 2019Revenue20.8 +32.0%Operating income−25.5Net income−26.0Fiscal year 2020Revenue9.5 −54.1%Operating income−71.5Net income−72.1Fiscal year 2021Revenue12.4 +29.6%Operating income−202.9Net income−203.7EPS, diluted−7.74Fiscal year 2022Revenue206.0 +1,566.8%Operating income12.2Net income9.3EPS, diluted0.35Fiscal year 2023Revenue166.8 −19.0%Operating income−78.2Net income−29.7 −417.9%EPS, diluted−1.12 −420.0%Fiscal year 2024Revenue152.3 −8.7%Operating income−95.7Net income−80.9EPS, diluted−3.00Fiscal year 2025Revenue82.0 −46.1%Operating income−76.3Net income−65.8EPS, diluted−2.40
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 15.8 20.8 9.5 12.4 206.0 166.8 152.3 82.0
Growth +32.0% −54.1% +29.6% +1,566.8% −19.0% −8.7% −46.1%
Operating income −21.8 −25.5 −71.5 −202.9 12.2 −78.2 −95.7 −76.3
Net income −21.8 −26.0 −72.1 −203.7 9.3 −29.7 −80.9 −65.8
Growth −417.9%
EPS, diluted n/a n/a n/a −7.74 0.35 −1.12 −3.00 −2.40
Growth −420.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Operating margin−138.5%Net margin−138.3%Free cash flow margin−141.2%Fiscal year 2019Operating margin−122.7%Net margin−125.0%Free cash flow margin−34.9%Fiscal year 2020Operating margin−749.8%Net margin−756.3%Free cash flow margin−467.6%Fiscal year 2021Operating margin−1,641.3%Net margin−1,648.0%Free cash flow margin−1,120.2%Fiscal year 2022Operating margin5.9%Net margin4.5%Free cash flow margin11.8%Fiscal year 2023Operating margin−46.9%Net margin−17.8%Free cash flow margin−12.6%Fiscal year 2024Operating margin−62.8%Net margin−53.1%Free cash flow margin−39.7%Fiscal year 2025Operating margin−93.0%Net margin−80.2%Free cash flow margin−90.8%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −138.5% −122.7% −749.8% −1,641.3% 5.9% −46.9% −62.8% −93.0%
Net margin −138.3% −125.0% −756.3% −1,648.0% 4.5% −17.8% −53.1% −80.2%
Free cash flow margin −141.2% −34.9% −467.6% −1,120.2% 11.8% −12.6% −39.7% −90.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−20.8Capital expenditure−1.5Free cash flow−22.2Fiscal year 2019Operating cash flow−6.4Capital expenditure−0.8Free cash flow−7.3Fiscal year 2020Operating cash flow−42.9Capital expenditure−1.7Free cash flow−44.6Fiscal year 2021Operating cash flow−135.0Capital expenditure−3.4Free cash flow−138.4Fiscal year 2022Operating cash flow32.0Capital expenditure−7.7Free cash flow24.3Fiscal year 2023Operating cash flow−18.1Capital expenditure−2.9Free cash flow−21.0 −186.5%Fiscal year 2024Operating cash flow−59.7Capital expenditure−0.6Free cash flow−60.4Fiscal year 2025Operating cash flow−74.3Capital expenditure−0.2Free cash flow−74.5
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −20.8 −6.4 −42.9 −135.0 32.0 −18.1 −59.7 −74.3
Capital expenditure −1.5 −0.8 −1.7 −3.4 −7.7 −2.9 −0.6 −0.2
Free cash flow −22.2 −7.3 −44.6 −138.4 24.3 −21.0 −60.4 −74.5
Growth −186.5%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash36.7Total debt9.9Net cash (debt)26.8Shareholders’ equity13.6Debt to equity0.73Fiscal year 2019Cash71.4Total debt15.0Net cash (debt)56.4Shareholders’ equity25.8Debt to equity0.58Fiscal year 2020Cash462.9Total debt15.1Net cash (debt)447.8Shareholders’ equity396.6Debt to equity0.04Fiscal year 2021Cash370.5Total debt63.1Net cash (debt)307.4Shareholders’ equity228.2Debt to equity0.28Fiscal year 2022Cash391.9Total debt60.7Net cash (debt)331.2Shareholders’ equity270.3Debt to equity0.22Fiscal year 2023Cash292.0Shareholders’ equity278.5Fiscal year 2024Cash237.0Shareholders’ equity241.0Fiscal year 2025Cash230.9Shareholders’ equity214.0
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 36.7 71.4 462.9 370.5 391.9 292.0 237.0 230.9
Total debt 9.9 15.0 15.1 63.1 60.7 n/a n/a n/a
Net cash (debt) 26.8 56.4 447.8 307.4 331.2 n/a n/a n/a
Shareholders’ equity 13.6 25.8 396.6 228.2 270.3 278.5 241.0 214.0
Debt to equity 0.73 0.58 0.04 0.28 0.22 n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
36.7 71.4 462.9 370.5 391.9 292.0 237.0 230.9
4.5 2.2 2.1 3.4 2.8 32.1 4.0 5.6
2.0 2.3 3.4 5.6 12.4 12.4 9.5 6.7
44.2 82.1 476.5 392.8 450.4 429.4 344.1 271.1
Growth +85.9% +480.0% −17.6% +14.7% −4.7% −19.9% −21.2%
Liabilities
n/a n/a 1.3 22.5 60.7 n/a n/a n/a
9.9 15.0 13.8 40.6 n/a n/a n/a n/a
calc 9.9 15.0 15.1 63.1 60.7 n/a n/a n/a
30.6 56.4 79.9 164.6 180.1 150.9 103.1 57.2
Equity
−44.9 −71.7 −143.8 −347.5 −338.1 −367.9 −448.8 −514.6
13.6 25.8 396.6 228.2 270.3 278.5 241.0 214.0
Growth +89.1% +1,437.5% −42.5% +18.4% +3.0% −13.5% −11.2%
Per share and net cash
calc 26.8 56.4 447.8 307.4 331.2 n/a n/a n/a
10.7 15.1 26.2 26.4 26.6 26.8 27.0 28.4
calc 1.27 1.70 15.14 8.65 10.18 10.38 8.93 7.53

Lines marked calc are worked out here from filed figures; point at one for how.